abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

文章

2009年1月30日

作者:
Pfizer

[PDF] Pfizer Responds to Divided Ruling by U.S. Court of Appeals for 2nd Circuit in Cases Related to Trovan Study in Nigeria

Pfizer released the following statement in reaction to today’s divided ruling by the U.S. Court of Appeals for the Second Circuit, remanding two cases...brought by Nigerian residents in the U.S. District Court for the Southern District of New York. Plaintiffs are seeking damages under international law in connection with the company’s 1996 Trovan clinical study. "The Appeals Court’s divided decision is only a procedural ruling that may return the cases to the District Court for further consideration; it is not a determination on their merits.... Pfizer remains confident that it will prevail in these cases... “The 1996 Trovan clinical study in Kano was conducted with the approval of the Nigerian government, and consent of the participants’ parents or guardians, and was consistent with both international and Nigerian laws..."

屬於以下案件的一部分

US lawyer tells story of lawsuit against Pfizer over Nigerian drug trials that allegedly led to deaths of children

Pfizer lawsuit (re administration of experimental drug in Nigeria, filed in USA)